Subjects: ANTINEOPLÁSICOS, LEUCEMIA, MEIA IDADE, ESTUDOS RETROSPECTIVOS, TAXA DE SOBREVIVÊNCIA, RESULTADO DE TRATAMENTO
ABNT
SILVA, Wellington Fernandes da et al. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience. Clinics, v. 75, 2020Tradução . . Disponível em: https://doi.org/10.6061/clinics/2020/e1566. Acesso em: 04 out. 2024.APA
Silva, W. F. da, Rosa, L. I. da, Seguro, F. S., Silveira, D. R. A., Bendit, I., Buccheri, V., et al. (2020). Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience. Clinics, 75. doi:10.6061/clinics/2020/e1566NLM
Silva WF da, Rosa LI da, Seguro FS, Silveira DRA, Bendit I, Buccheri V, Velloso EDRP, Rocha VG, Rego EM. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience [Internet]. Clinics. 2020 ; 75[citado 2024 out. 04 ] Available from: https://doi.org/10.6061/clinics/2020/e1566Vancouver
Silva WF da, Rosa LI da, Seguro FS, Silveira DRA, Bendit I, Buccheri V, Velloso EDRP, Rocha VG, Rego EM. Salvage treatment for refractory or relapsed acute myeloid leukemia: a 10-year single-center experience [Internet]. Clinics. 2020 ; 75[citado 2024 out. 04 ] Available from: https://doi.org/10.6061/clinics/2020/e1566